Pain Home > Relafen

Relafen belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). While this medication has been licensed to treat the symptoms of osteoarthritis and rheumatoid arthritis, it is not a cure -- nor does it slow down the progression of the disease. Relafen comes in the form of a tablet that is taken by mouth. Common side effects include swelling, unexplained rash, and constipation.

What Is Relafen?

Relafen® (nabumetone) is a prescription medicine used to treat pain, inflammation, swelling, and/or stiffness. It belongs to a class of drugs called nonsteroidal anti-inflammatory drugs, or NSAIDs for short.

Who Makes It?

Relafen is manufactured by GlaxoSmithKline.

What Is Relafen Used For?

Relafen has been licensed for the relief of signs and symptoms of osteoarthritis and rheumatoid arthritis. However, the medication is not a cure for these types of arthritis, nor does it slow the progression of the disease.
(Click Relafen Uses for more information on these uses, as well as possible off-label uses for Relafen.)

How Does It Work?

Relafen and other NSAIDs work by inhibiting the action of certain hormones that cause inflammation and pain in the body. These hormones are called prostaglandins.

Effects of Relafen

By blocking the effects of prostaglandins, Relafen is useful at reducing pain, inflammation, and joint swelling associated with different forms of arthritis and painful conditions.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.